Skip to main content
. Author manuscript; available in PMC: 2010 Sep 8.
Published in final edited form as: Br J Haematol. 2008 Mar 17;145(4):506–513. doi: 10.1111/j.1365-2141.2009.07658.x

Table 1.

Arginine Metabolites in SCD vs. controls. Values indicate median plasma levels at steady state in micromolar. Results are compared for control subjects compared to all SCD patients, and then the same SCD patients categorized by genotype.

Arginine
Metabolite
Control
(n=29)
All SCD
(n=177)
SS
(n=130)
0-thal
(n=3)
SC
(n=34)
+-thal
(n=8)
ADMA 0.31 0.94 *** 0.99*** 1.48*** 0.82*** 0.78
SDMA 0.83 1.02 *** 1.03** 1.04 0.92 0.98
L-NMMA 0.13 0.18 *** 0.18*** 0.23 0.15 0.17
L-Arginine 78.3 46.4 *** 45.5*** 28.5* 51.5** 42.7**
NOHA 2.50 1.93 ** 1.80* 2.15 2.23 2.11
Citrulline 20.1 17.7 * 17.0* 19.1 21.1 20.6
*

p<0.05 compared to control

**

p<0.01

***

p<0.001; Mann-Whitney test for all SCD compared to control subjects; Kruskal-Wallis test with Dunne’s post-test for comparisons of genotype categories to control subjects.